Announced that The Brazilian regulatory agency ANVISA has ap...
Announced that The Brazilian regulatory agency ANVISA has approved the commencement of additional Phase 3 clinical trials of Leronlimab in certain Novel Coronavirus-19 patients.
The trial will focus on hospitalized critically ill patients requiring mechanical and invasive ventilation or extracorporeal membrane oxygenation. $CYTODYN INC (CYDY.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment